Cargando…

Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature

Deferoxamine mesylate (DFO) is the most commonly used iron-chelating agent to treat transfusion-related hemosiderosis. Despite the clear advantages for the use of DFO, numerous DFO-related systemic toxicities have been reported in the literature, as well as sight-threatening ocular toxicity involvin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Nicola, Maura, Barteselli, Giulio, Dell'Arti, Laura, Ratiglia, Roberto, Viola, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475708/ https://www.ncbi.nlm.nih.gov/pubmed/26167477 http://dx.doi.org/10.1155/2015/249617

Ejemplares similares

Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula
por: Dell’Arti, Laura, et al.
Publicado: (2018)

Deferoxamine retinopathy: spectral domain-optical coherence tomography findings
por: Wu, Cheng-Hsiu, et al.
Publicado: (2014)

Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration
por: Nassisi, Marco, et al.
Publicado: (2023)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies
por: Barteselli, Giulio, et al.
Publicado: (2022)

Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature
por: Georgakopoulos, Constantine D., et al.
Publicado: (2018)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada, Francisco, et al.
Publicado: (2012)

Abstract: Deferoxamine Increases Breast Cancer Radiosensitivity
por: Ranganathan, Kavitha, et al.
Publicado: (2018)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021)

Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth
por: Lee, Ko Eun, et al.
Publicado: (2021)

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022)

Expanding the clinical spectrum of the mitochondrial mutation A13084T in the ND5 gene
por: Brusa, Roberta, et al.
Publicado: (2020)

Restoring the Secretory Function of Irradiation-Damaged Salivary Gland by Administrating Deferoxamine in Mice
por: Zhang, Junye, et al.
Publicado: (2014)

Deferoxamine inhibition of malaria is independent of host iron status
Publicado: (1988)

Comparison of the effect of vanadium and deferoxamine on acetaminophen toxicity in rats
por: Najafzadeh, H., et al.
Publicado: (2011)

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Deferoxamine therapy for intracerebral hemorrhage: A systematic review
por: Zeng, Liling, et al.
Publicado: (2018)

Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism
por: Yang, Yujing, et al.
Publicado: (2018)

The effect of deferoxamine injection on composite graft survival in rabbits
por: Ramli, Rianto Noviady, et al.
Publicado: (2020)

The iron chelator deferoxamine decreases myeloma cell survival
por: Yang, Feifei, et al.
Publicado: (2021)

Effects of deferoxamine on intrinsic colistin resistance of Proteus mirabilis
por: Erinmez, Mehmet, et al.
Publicado: (2023)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats
por: Hao, Jian, et al.
Publicado: (2017)

Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells
por: Ghislanzoni, Silvia, et al.
Publicado: (2023)

Clinical applications of choroidal imaging technologies
por: Chhablani, Jay, et al.
Publicado: (2015)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage
por: Yu, Yao, et al.
Publicado: (2015)

Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
por: Zhang, Xiao-Ying, et al.
Publicado: (2015)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
por: Donneys, Alexis, et al.
Publicado: (2018)

Deferoxamine synergizes with transforming growth factor-β signaling in chondrogenesis
por: Huang, Zheng, et al.
Publicado: (2017)

Deferoxamine accelerates endothelial progenitor cell senescence and compromises angiogenesis
por: Lee, Yi-Nan, et al.
Publicado: (2021)

Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator
por: Bellotti, Denise, et al.
Publicado: (2021)

Testing of the siderophore deferoxamine amended in hydrogels for the cleaning of iron corrosion
por: Cuvillier, Luana, et al.
Publicado: (2023)

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
por: Smith, Gillian C, et al.
Publicado: (2011)

Executive function abnormalities in pathological gamblers
por: Marazziti, Donatella, et al.
Publicado: (2008)

Abstract: Implantable Deferoxamine Facilitates Non-Vascularized Grafting in Irradiated Bone
por: Donneys, Alexis, et al.
Publicado: (2017)

Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis
por: Yao, Xue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nhbsosf7cfr19sdk4jpkg913s1